Transcription of INJECTABLE DRUG DELIVERY 2013: …
{{id}} {{{paragraph}}}
Example: bankruptcy
INJECTABLE DRUG DELIVERY 2013: …
JULY 2013 ISSUE NO 43 ISSN-2049-145 XINJECTABLE drug DELIVERY 2013 :FORMULATIONS FOCUS1024_GF_ONdrugDeilvery_June Inj 11024_GF_ONdrugDeilvery_June Inj 105/07/ 2013 09:1605/07/ 2013 09:162 CONTENTSS mart Formulations of Liquid BiotherapeuticsDr Jan Jezek, Chief Scientific OfficerArecor Ltd 4-7 Using Half-Life Extension to Move a Pioneering treatment for AutoimmuneDiseases Towards Clinical TrialsDr Mark Perkins, Customer Solution Manager Novozymes Biopharma US, Inc and Dr Anne S. De Groot, Chief Executive Officer & Chief Scientific OfficerEpiVax, Inc 10-12 Self-Interaction Chromatography Lends Insight into Formulation StudiesDr Michelle Amaral, Science Writer/PR ConsultantSoluble Therapeutics, Inc 14-15 Syringe Siliconisation: Trends, Methods, Analysis ProceduresClaudia Petersen, Global Director, Marketing & DevelopmentGerresheimer B nde GmbH 16-19 Copyright 2013 Frederick Furness Publishing LtdThe views and opinions expressed in this issue are those of the authors.
ONdrugDelivery 2013/14 EDITORIAL CALENDAR Publication Month Issue Topic Materials Deadline September 2013 Drug Formulation & Delivery Solutions & Services 2013 …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: